Canada · Delayed Price · Currency is CAD Revance Therapeutics Statistics
Total Valuation
NEO:GS has a market cap or net worth of CAD 286.94 billion.
| Market Cap | 286.94B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Wednesday, July 16, 2025.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -4.24% |
| Shares Change (QoQ) | -1.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 291.04M |
Valuation Ratios
The trailing PE ratio is 14.30 and the forward PE ratio is 13.58.
| PE Ratio | 14.30 |
| Forward PE | 13.58 |
| PS Ratio | 3.84 |
| PB Ratio | 1.70 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.66, with a Debt / Equity ratio of 5.32.
| Current Ratio | 2.66 |
| Quick Ratio | 2.03 |
| Debt / Equity | 5.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.76%.
| Return on Equity (ROE) | 12.76% |
| Return on Assets (ROA) | 0.91% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.63M |
| Profits Per Employee | 437,059 |
| Employee Count | 46,500 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NEO:GS has paid 5.85 billion in taxes.
| Income Tax | 5.85B |
| Effective Tax Rate | 21.60% |
Stock Price Statistics
The stock price has increased by +36.28% in the last 52 weeks. The beta is 1.34, so NEO:GS's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +36.28% |
| 50-Day Moving Average | 32.77 |
| 200-Day Moving Average | 29.67 |
| Relative Strength Index (RSI) | 54.85 |
| Average Volume (20 Days) | 12,612 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.77 |
Income Statement
In the last 12 months, NEO:GS had revenue of CAD 74.73 billion and earned 20.06 billion in profits. Earnings per share was 61.84.
| Revenue | 74.73B |
| Gross Profit | 61.86B |
| Operating Income | 27.38B |
| Pretax Income | 27.07B |
| Net Income | 20.06B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 61.84 |
Balance Sheet
The company has 1.07 trillion in cash and 900.15 billion in debt, giving a net cash position of 165.03 billion.
| Cash & Cash Equivalents | 1.07T |
| Total Debt | 900.15B |
| Net Cash | 165.03B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 169.12B |
| Book Value Per Share | 473.23 |
| Working Capital | 1.32T |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 82.78%, with operating and profit margins of 36.64% and 28.40%.
| Gross Margin | 82.78% |
| Operating Margin | 36.64% |
| Pretax Margin | 36.22% |
| Profit Margin | 28.40% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NEO:GS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.24% |
| Shareholder Yield | n/a |
| Earnings Yield | 6.99% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |